Pacific Biosciences of California (PACB) — Working Capital to Net Assets Ratio
Pacific Biosciences of California (PACB) has a Working Capital to Net Assets ratio of -812.4% as of June 2026. Working capital of $269.83 Million (current assets of $338.64 Million minus current liabilities of $68.81 Million) is measured against net assets of $-33.21 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Pacific Biosciences of California Working Capital to Net Assets (2008–2025)
This chart shows how Pacific Biosciences of California's Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the ratio stands at -812.4%, reflecting working capital of $269.83 Million against net assets of $-33.21 Million USD. See PACB cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Pacific Biosciences of California (2008–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Pacific Biosciences of California from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Pacific Biosciences of California.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 5993.9% | $320.62 Million | $5.35 Million | $375.03 Million | $54.42 Million | ▲ +5909.2 pp |
| 2024 | 84.8% | $429.38 Million | $506.59 Million | $495.68 Million | $66.30 Million | ▼ -7.5 pp |
| 2023 | 92.3% | $647.02 Million | $701.30 Million | $742.05 Million | $95.03 Million | ▼ -12.3 pp |
| 2022 | 104.6% | $588.74 Million | $562.90 Million | $852.07 Million | $263.33 Million | ▼ -25.6 pp |
| 2021 | 130.1% | $1.03 Billion | $790.99 Million | $1.10 Billion | $71.71 Million | ▲ +35.6 pp |
| 2020 | 94.5% | $317.08 Million | $335.49 Million | $355.59 Million | $38.50 Million | ▲ +36.4 pp |
| 2019 | 58.1% | $31.89 Million | $54.92 Million | $81.05 Million | $49.15 Million | ▼ -39.5 pp |
| 2018 | 97.6% | $111.31 Million | $114.06 Million | $131.66 Million | $20.35 Million | ▲ +5.5 pp |
| 2017 | 92.1% | $79.30 Million | $86.10 Million | $101.62 Million | $22.32 Million | ▲ +3.2 pp |
| 2016 | 88.9% | $75.24 Million | $84.67 Million | $109.01 Million | $33.77 Million | ▼ -31.6 pp |
| 2015 | 120.5% | $88.61 Million | $73.54 Million | $110.54 Million | $21.93 Million | ▼ -36.5 pp |
| 2014 | 157.0% | $86.27 Million | $54.95 Million | $117.76 Million | $31.49 Million | ▲ +6.8 pp |
| 2013 | 150.2% | $103.90 Million | $69.18 Million | $126.46 Million | $22.55 Million | ▲ +58.5 pp |
| 2012 | 91.7% | $100.26 Million | $109.38 Million | $115.00 Million | $14.74 Million | ▼ -2.5 pp |
| 2011 | 94.1% | $180.22 Million | $191.46 Million | $199.60 Million | $19.38 Million | ▼ -3.2 pp |
| 2010 | 97.3% | $272.27 Million | $279.87 Million | $293.11 Million | $20.84 Million | ▲ +145.5 pp |
| 2009 | -48.2% | $85.33 Million | $-177.12 Million | $93.75 Million | $8.42 Million | ▲ +61.3 pp |
| 2008 | -109.5% | $102.22 Million | $-93.39 Million | $106.93 Million | $4.70 Million | — |